Karin Leandersson

16PUBLICATIONS
38CO-AUTHORS
Predictive and prognostic markersTumour immunologyAutoimmunityEpigenetics (incl. genome methylation and epigenomics)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Mar 20, 2026
Tumor-Infiltrating Immune Cells Are More Abundant in Lung Metastases From Colorectal Cancer Than in Paired Primary Tumors and Their Prognostic Value Depends on Adjuvant Chemotherapy.

Danyil Kuznyecov, Christina Siesing, Halla Vidarsdottir

|Apr 11, 2025
Altered immune signatures in breast cancer lymph nodes with metastases revealed by spatial proteome analyses.

Oscar Briem, Balázs Tahin, Asger Meldgaard Frank

|Oct 08, 2024
Complement Factor H Is an ICOS Ligand Modulating Tregs in the Glioma Microenvironment.

Karolina I Smolag, Jakub Olszowka, Rebecca Rosberg

|Dec 07, 2023
AIRE is expressed in breast cancer TANs and TAMs to regulate the extrinsic apoptotic pathway and inflammation.

Eva Källberg, Meliha Mehmeti-Ajradini, Frida Björk Gunnarsdottir

|Feb 25, 2023
CD169+ Macrophages in Primary Breast Tumors Associate with Tertiary Lymphoid Structures, Tregs and a Worse Prognosis for Patients with Advanced Breast Cancer.

Oscar Briem, Eva Källberg, Siker Kimbung

|Dec 01, 2022
The injury-induced transcription factor SOX9 alters the expression of LBR, HMGA2, and HIPK3 in the human kidney.

Michelle Kha, Krzysztof Krawczyk, Oi Kuan Choong

Pageof 3

Frequent Collaborators

3 joint publications

Lisa Rydén

2 joint publications

Karin Jirström

1 joint publications

Daniel Bexell

1 joint publications

Anna Ehinger